A federal judge in Eugene, Oregon, said Thursday he would block Health Secretary Robert F. Kennedy Jr.'s effort to restrict medical providers from offering gender-related treatments to minors.
U.S. District Judge Mustafa Kasubhai announced at the end of a lengthy hearing that he would grant a summary judgment motion brought by attorneys general from 19 states and Washington, D.C., who sued to stop the policy.
According to Newsmax, Kasubhai also denied the Department of Health and Human Services' bid to dismiss the lawsuit entirely.
The ruling hands a win to a coalition of Democrat-led states that challenged Kennedy's December declaration, which stated that HHS could bar healthcare providers offering gender treatments to children from participating in Medicaid and Medicare. The declaration also said HHS could prohibit the Children's Health Insurance Program from covering such procedures.
Kennedy's declaration was grounded in a straightforward medical judgment. His agency reviewed the available evidence on treatments for children and adolescents diagnosed with gender dysphoria and concluded they carried an "unfavorable risk-benefit profile."
That's not a culture-war talking point. It's a clinical assessment, and one that aligns with the conclusions reached by national health authorities in England, Sweden, Finland, Denmark, and other European countries that have moved to sharply curtail or ban puberty blockers and cross-sex hormones for minors in recent years. The international medical consensus has been shifting, and Kennedy's declaration reflected that shift.
The states sued in December, just days after the declaration was issued, framing it as federal overreach. But there's nothing unusual about a federal agency conditioning participation in taxpayer-funded programs on evidence-based standards. That is, in fact, the entire purpose of HHS oversight.
New York Attorney General Letitia James, one of the plaintiffs, celebrated the ruling in a statement, claiming it "gives some needed clarity to patients, families, and providers."
James went further:
"Health care services for transgender young people remain legal, and the federal government cannot intimidate or punish the providers who offer them."
Nobody proposed criminalizing anything. Kennedy's declaration addressed federal funding, specifically whether taxpayer dollars through Medicaid, Medicare, and CHIP should subsidize treatments his agency determined carry risks that outweigh benefits for minors. There is a vast difference between something being legal and something being entitled to public funding. James knows this. The conflation is deliberate.
This is a familiar rhetorical move from the left: reframe any limitation on government subsidy as a "ban," then claim the moral high ground by defending access that was never actually threatened. You can walk into any private clinic in New York tomorrow and receive these treatments. What Kennedy challenged was whether the federal government should be writing the check.
The case fits neatly into a pattern that has defined progressive legal strategy throughout the current administration. The playbook is simple:
Eugene, Oregon, is not exactly hostile terrain for this kind of challenge. Judge Kasubhai's ruling will almost certainly be appealed, and the legal questions around HHS authority over program funding standards are far from settled. But the initial headline belongs to the plaintiffs, and that's often the point.
Meanwhile, the underlying medical debate continues to evolve in one direction. Country after country has pulled back from the aggressive treatment model that American progressives treat as settled science. England's Cass Review, the most comprehensive independent analysis of pediatric gender medicine ever conducted, found the evidence base for these interventions "remarkably weak." Scandinavian countries that once pioneered youth gender medicine have reversed course.
American progressives are increasingly alone on the international stage in insisting that skepticism of these treatments constitutes bigotry rather than prudence.
The administration has made its position on these issues clear across multiple fronts, and this ruling, while a setback in one courtroom, does not change the broader trajectory. Legal challenges will continue. The evidence will continue to accumulate. And parents across the country will continue to ask why the most aggressive treatment protocols for minors are treated as untouchable by the same political class that demands "follow the science" on every other issue.
Nineteen attorneys general went to court to ensure that taxpayer money keeps flowing to procedures that even progressive European governments now restrict. That tells you everything about where their priorities actually sit.